MARCH8 antibody
Principal name
MARCH8 antibody
Alternative names for MARCH8 antibody
MARCH-VIII, c-MIR, Membrane-associated RING finger protein 8, RNF178, E3 ubiquitin-protein ligase MARCH8, Cellular modulator of immune recognition, RING finger protein 178
Ncbi ID
9606, NP_001002265, NP_659458, NP_001002265.1, NP_001002266, NP_082196.1, NM_001002266, NM_145021
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of MARCH8 antibody
- Kit Component:
- - KN309791G1, March8 gRNA vector 1 in pCas-Guide vector
- KN309791G2, March8 gRNA vector 2 in pCas-Guide vector
- KN309791D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human PANC1; WB Suggested Anti-MARCH8 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: PANC1 cell lysate. MARCH8 is supported by BioGPS gene expression data to be expressed in PANC1.; MARCH8 antibody - N-terminal region (ARP42958_P050) in Human PANC1 cells using Western Blot
Human NCI-H226; WB Suggested Anti-MARCH8 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: NCI-H226 cell lysate; MARCH8 antibody - middle region (ARP42959_P050) in Human NCI-H226 cells using Western Blot
Human Muscle; WB Suggested Anti-MARCH8 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:12500. Positive Control: Human Muscle; MARCH8 antibody - middle region (ARP43401_P050) in Human Muscle cells using Western Blot
Human Placenta: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Prostate: Formalin-Fixed, Paraffin-Embedded (FFPE)
Immunocytochemistry in HeLa cells with MARCH8 antibody (AP23000PU-N) at 2.5 µg/ml.
Western blot analysis of MARCH8 in HeLa cell lysate with MARCH8 antibody (AP23000PU-N) at (A) 0.5 ug/ml and (B) 1 µg/ml
Western blot analysis of MARCH8 in HeLa cell lysate with MARCH8 antibody at (A) 0.5 ug/ml and (B) 1 ug/ml.
Immunocytochemistry of MARCH8 in HeLa cells with MARCH8 antibody at 2.5 ug/ml.
WB Suggested Anti-MARCH8 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:12500; Positive Control: Human Muscle
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP23000PU-N | MARCH8 (C-term) antibody |
||||||
 |
Rabbit | Purified | Hu, Ms, Rt | E, ICC/IF, P, WB |
50 µg /
€380.00
|
||
| Acris Antibodies GmbH | |||||||
 +3 additional images |
Highly validated antibody! |
||||||
| TA306677 | MARCH8 antibody |
||||||
| Rabbit Polyclonal MARCH8 Antibody | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu, Ms, Rt | E, ICC/IF, WB |
0.1 mg /
€371.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA330501 | MARCH8 antibody |
||||||
| Rabbit Polyclonal Anti-MARCH8 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN205477 | MARCH8 - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN205477BN | MARCH8 - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN205477LP | MARCH8 - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN205477RB | MARCH8 - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN309791 | March8 - mouse gene knockout kit via CRISPR |
||
|
Mouse | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN309791BN | March8 - mouse gene knockout kit via CRISPR |
||
|
Mouse | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN309791LP | March8 - mouse gene knockout kit via CRISPR |
||
|
Mouse | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN309791RB | March8 - mouse gene knockout kit via CRISPR |
||
|
Mouse | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP305477 | MARCH8 (transcript variant 7) |
||||
| Recombinant protein of human membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 7 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€438.00
|
|
| OriGene Technologies, Inc. | |||||
|
|||||
| TP309891 | MARCH8 (transcript variant 8) |
||||
| Recombinant protein of human membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 8 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC209891L2V | Lenti ORF particles, MARCH8 (mGFP-tagged) - Human membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€989.00
|
|
| OriGene Technologies, Inc. | ||
| RC209891L1V | Lenti ORF particles, MARCH8 (Myc-DDK tagged) - Human membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 2 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€886.00
|
|
| OriGene Technologies, Inc. | ||
| RC205477L1V | Lenti ORF particles, MARCH8 (Myc-DDK tagged) - Human membrane-associated ring finger (C3HC4) 8 (MARCH8), transcript variant 3 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€886.00
|
|
| OriGene Technologies, Inc. | ||
